Trial Profile
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 06 Jan 2020 Planned End Date changed from 1 Nov 2019 to 1 Nov 2020.
- 06 Jan 2020 Planned primary completion date changed from 1 Nov 2019 to 1 Nov 2020.
- 03 Dec 2018 Planned End Date changed from 1 Apr 2019 to 1 Nov 2019.